Navigation Links
Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
Date:10/31/2013

r share:Diluted:Total adjustments to net income (loss)$
7.13
$
3.38
Shares used in per share computation322,949313,584(a) See footnote (a) to Table 2a.(b) ASC 805, accounting for business combinations requires an inventory fair value step-up whose total impact for the nine months ended September 30, 2013 is $219.2 million primarily relating to the acquisition of Bausch & Lomb Holdings Incorporated on August 5, 2013 and Medicis Pharmaceutical Corporation on December 11, 2012.  For the nine months ended September 30, 2012 the impact of inventory fair value step-up is $49.4 million primarily relating to the acquisitions of  iNova on December 21, 2011, Dermik on December 16, 2011, Afexa Life Sciences on October 17, 2011, Ortho Dermatologics on December 12, 2011 and Pedinol Pharmacal, Inc. on April 11, 2012.(c) For the nine months ended September 30, 2013 and 2012 cost of goods include costs associated with integration related tech transfers, $25.4 million and $18.9 million, respectively.  For the nine months ended September 30, 2013 cost of goods include amortization of a BMS fair value inventory adjustment of $5.0 million.(d) Cost of alliances represents the divestiture of 5-FU and IDP-111 resulting from the acquisition of Dermik, $50.9 million for the nine months ended September 30, 2012. (e) For the nine months ended September 30, 2013 and 2012 SG&A primarily includes $20.9 million and $26.8 million of stock-based compensation, respectively, which reflects the one time modification and cash settlement of certain board of directors equity instruments, acceleration of certain equity instruments and the amortization of the fair value step-up increment resulting from the merger of Legacy Valeant into Legacy Biovail.(f) SG&A includes $1.0 million loss on assets held for sale/impairment for the nine months ended September 3
'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Inc. (ICBU) has repositioned itself as a holding company with ... in the hydroponic, hemp and medical marijuana sectors. By acquiring ... sector, and recently partnering with the Chippewa Tribe Nation to ... iMD is committing to bring its vision to the market ...
(Date:1/23/2015)... 2015   Leatt Corporation  (OTCQB: LEAT), a global developer, ... forms of sports, including extreme motor sports, and whose ... that the UISP Lega Motociclismo Lombardia, an Italian motocross ... wear a neck brace during its racing competitions.  ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced today ... been enrolled into the Company,s Phase 2 clinical trial. ... of Gem,s lead compound, GPX-150 (an investigational medication), in ... metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... Medical Group,s (FMG) subsidiaries, VasoStar Inc., Mentor, Ohio  today ... Frontier grant to further develop and commercialize a novel ... Occlusions (CTOs), in lieu of invasive open heart surgery ... VasoStar,s primary clinical development partner is the Cleveland ...
... July 20, 2011 Advanced Health Media (AHM), the ... solutions for the pharmaceutical industry, has named James Burgess ... assumes responsibility from Jeff Brady who has served as ... as its President for 9 years. James brings over ...
Cached Medicine Technology:Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 2Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 3Advanced Health Media Announces New CEO 2
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Four years since the ... – which coincided with the marriage of Avasa & Matthew Love ... ROAD, which is scheduled for release through White Swan Records on ... that there is a sacred path available to all of us ...
(Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... ANA, Calif., Jan. 9 Grubb & Ellis,Healthcare REIT, ... two-property medical office building portfolio in San Antonio and,the ... acquisition closed in,December 2008. , ... Pecan Valley Medical,Office Building consists of approximately 60,000 square ...
... , NEW YORK, Jan. 9 A ... of juvenile myelomonocytic leukemia (JMML), a very rare form ... cord blood from the National Cord Blood Program (NCBP) of ... Blood Center.Juvenile myelomonocytic leukemia generally affects children under the age ...
... Study found impairments were mild, but they could signal ... Adults with diabetes now have to worry about whether ... report that declines in mental function are accelerated among ... analysis, published in the January issue of Neuropsychology ...
... The University of Texas Health Science Center at Houston ... in a ground-breaking area of genetic study known as ... to discover why some people with known risk factors ... may have to do with the interplay between their ...
... Jan. 9 Blue Shield of California has ... manage the company,s rapid growth and pursue new strategic initiatives. ... spearhead the company,s success, Blue Shield chairman and CEO Bruce ... , Paul Markovich, ...
... A study published today in The,Journal of Occupational and ... price tag for lupus - including medical,expenditures, absence from ... per patient. The mean cost climbed to more than ... disease nephritis, as it,often is. That,s more than the ...
Cached Medicine News:Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 2Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 3Health News:Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas 4Health News:Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer 2Health News:Diabetes Linked to Cognitive Problems 2Health News:UT leads $2.5 million training program in pioneering area of genetic research 2Health News:UT leads $2.5 million training program in pioneering area of genetic research 3Health News:Paul Markovich Named Chief Operating Officer of Blue Shield of California 2Health News:Paul Markovich Named Chief Operating Officer of Blue Shield of California 3Health News:Lupus is a Significant Cost to Employers, According to Thomson Reuters Study 2Health News:Lupus is a Significant Cost to Employers, According to Thomson Reuters Study 3